Publication | Open Access
Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual<i>ERBB2</i>Blockade in Patients With<i>ERBB2</i>-Positive Breast Cancer
130
Citations
22
References
2021
Year
ClinicalTrials.gov Identifier: NCT01996267.
| Year | Citations | |
|---|---|---|
Page 1
Page 1